Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review - Quiz - MDSpire

Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review

  • By

  • Natalia Picheta

  • Julia Piekarz

  • Jakub Pobideł

  • Katarzyna Szklener

  • Magdalena Skórzewska

  • July 16, 2026

Share

Original Source(s)

Zolbetuximab in the treatment of advanced gastric and gastroesophageal junction cancer: a systematic review

  • by Natalia Picheta, Julia Piekarz, Jakub Pobideł, Katarzyna Szklener, Magdalena Skórzewska

  • July 16, 2026

Related Content

Age-stratified diagnostic performance of the ovarian-adnexal reporting and data system for adnexal masses: a focus on school-age children, early, and middle adolescents

Association of APOBEC mutagenesis with stromal and endothelial niche remodeling and PCDH9-linked signaling alterations in colorectal cancer

Cryoablation as an organ-preserving therapy for low rectal cancer a comprehensive protocol and institutional perspective